Clinical Study of Clinical Efficacy and Tolerability of hMG-IBSA s.c.in Women Undergoing COH in an ART Programme (IVF).
IBSA Institut Biochimique SA
Multicenter, prospective, randomized, investigator blind, controlled clinical trial. Two
parallel groups, one receiving the test drug hMG (hMG-IBSA, IBSA Institut Biochimique sa)
and the other the reference drug hMG (Menopur, Ferring Pharmaceuticals, Inc.).
What is the Best Preparation for Embryo Transfer in Cryo Cycles: a Natural Cycle or Light Hormonal Stimulation?
University Hospital, Gasthuisberg
The study investigates if, among women with a regular cycle (between 25 and 45 days), the
endometrium is better prepared for the transfer of an embryo that was cryopreserved and if
the subsequent embryo implantation rate is higher when the cycle is started with daily,
small-dose hormonal injections than in cycles without these daily injections.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.